Clinical Trial Detail
Contact
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04362072 |
| Title | Study of Lorlatinib In People With ALK-positive Non-small Cell Lung Cancer |
| Recruitment | Completed |
| Gender | both |
| Phase | FDA approved |
| Variant Requirements | Yes |
| Sponsors | Pfizer |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | POL | ITA | GBR | ESP | CHE |
CKB BOOST